ライフサイエンスコーパス: lower body negative pressure

1 an blood pressure variability by oscillatory lower body negative pressure.

2 , during decreased cardiac filling by use of lower-body negative pressure (-15 and -30 mm Hg), and af

3 P < 0.001) plasma norepinephrine response to lower body negative pressure (3.0 +/- 0.3 vs. 2.0 +/- 0.

4 Central hypovolemia was induced with lower body negative pressure (-60 mm Hg) and pain by the

5 on index are further reduced by hypovolemia (lower body negative pressure, -60 mm Hg).

6 rdiopulmonary baroreflexes were perturbed by lower body negative pressure and head-down tilt.

7 erformed while preload was manipulated using lower body negative pressure and rapid saline infusion t

8 onary capillary wedge pressure and SV during lower body negative pressure and saline loading in 7 men

9 ng curves were constructed during decreases (lower body negative pressure) and increases (saline infu

10 ring maneuvers, baseline, with two stages of lower body negative pressure, and repeat baseline with t

11 hocardiography at baseline, -15 and -30 mmHg lower-body negative pressure, and 15 and 30 ml kg(-1) sa

12 r mass (by echocardiography) at rest, during lower-body negative pressure, and after saline infusion

13 eline, during decreased cardiac filling with lower-body negative pressure, and increased filling with

14 Application of lower body negative pressure caused progressive reductio

15 bed rest with supine treadmill exercise in a lower-body negative pressure chamber (EX group).

16 slope of the line relating SV to PCWP during lower-body negative pressure characterized the steepness

17 Volume redistributions with lower body negative pressure (LBNP) are similar to those

18 sured for 10 min at rest and during 5 min of lower body negative pressure (LBNP) at -10 and -40 mmHg

19 -induced sympathetic activation, produced by lower body negative pressure (LBNP) at -40 mmHg, on cere

20 n sympathetic nerve activity (SNA) evoked by lower body negative pressure (LBNP) at rest and during m

21 (HG) and disengagement of baroreflexes with lower body negative pressure (LBNP) can engage the sympa

22 all subjects undergoing monitoring with the lower body negative pressure (LBNP) device.

23 humans, reflex sympathetic activation during lower body negative pressure (LBNP) evoked decreases in

24 bnormal forearm vasodilator responses during lower body negative pressure (LBNP) in 21 non-obstructiv

25 rded in humans (n = 20) during a progressive lower body negative pressure (LBNP) protocol designed to

26 nse to either carotid sinus massage (CSM) or lower body negative pressure (LBNP) received Paxil (20 m

27 Women underwent an initial maximal lower body negative pressure (LBNP) test to place them i

28 Progressive lower body negative pressure (LBNP) to onset of cardiova

29 compared when a cold pressor test (CPT) and lower body negative pressure (LBNP) were superimposed up

30 Reductions in were accomplished using lower body negative pressure (LBNP), while increases in

31 x activation of sympathetic nerves evoked by lower body negative pressure (LBNP).

32 ring reflex sympathetic activation evoked by lower body negative pressure (LBNP).

33 pressure were recorded during nonhypotensive lower body negative pressure (LBNP; -10 mm Hg) and nonhy

34 .7 degrees C, followed by the application of lower body negative pressure (LBNP; -30 mmHg).

35 easurements were also obtained during graded lower body negative pressure (LBNP; activates baroreflex

36 d while central blood volume was reduced via lower-body negative pressure (LBNP) during normothermia,

37 tic stress achieved by stepwise increases in lower-body negative pressure (LBNP) in 14 healthy young

38 FVR) during application of -20 and -30 mm Hg lower-body negative pressure (LBNP) in 24 patients with

39 atic tolerance was determined by progressive lower-body negative pressure (LBNP) to presyncope.

40 4 years) participants underwent progressive lower-body negative pressure (LBNP) until pre-syncope; e

41 hostatic tolerance was assessed using graded lower-body negative pressure (LBNP) until the onset of s

42 nary capillary wedge pressure (PCWP), during lower-body negative pressure (LBNP) while subjects are n

43 simulated haemorrhagic challenge imposed via lower-body negative pressure (LBNP).

44 Subjects experienced lower-body negative-pressure (LBNP) of 0, 15 and 30 mmHg

45 lacebo (0.9% NaCl) on endogenously mediated (lower body negative pressure [LBNP]) and exogenously med

46 tolerance to hypotensive hypovolemic stress (lower body negative pressure [LBNP]) in healthy human ma

47 ng 5 different loading conditions: baseline, lower-body negative pressures of -15 and -30 mm Hg, and

48 Oscillatory lower body negative pressure (OLBNP) was used to create

49 ing blood pressure fluctuations (oscillatory lower body negative pressure, OLBNP) across a range of f

50 med in a 2x2 fashion with the combination of lower body negative pressure or not (normovolemia), and

51 y (0.15-0.4 Hz) decreased progressively with lower body negative pressure (p < .001).

52 evere preload reduction using a standardized lower-body negative pressure protocol.

53 After completing a maximal lower body negative pressure test to determine level of

54 Progressive lower-body negative pressure (to -50 mm Hg; LBNP) was us

55 ood pressure was associated with 23% greater lower body negative pressure tolerance using an active i

56 Lower body negative pressure tolerance was reduced after

57 in human volunteers by applying progressive lower body negative pressure (under two experimental con

58 Oscillatory lower body negative pressure was applied at six frequenc

59 Progressive lower body negative pressure was applied in 5-min stages

60 did not differ when a cold pressor test and lower body negative pressure were superimposed upon heat